This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Régional Universitaire De Besançon, Etablissement Francais Du Sang, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 29 
1 out of 17 
Years Active: 2026
Title: Elodie Bole-Richard: Inventor in Biomedical Research.
Introduction
Elodie Bole-Richard is an inventor associated with Paris, France. Her patent work concerns CD123-targeted approaches in biomedical research.
Latest Patents
The available information lists one patent for Bole-Richard: “Anti-CD123 Antibodies, Anti-CD123 Chimeric Antigen Receptors and Anti-CD123 Chimeric Antigen Receptor T Cells.” 1 patent
Career Highlights
Bole-Richard is associated with Université de Franche-Comté and the French National Institute of Health and Medical Research (INSERM). The listed patent focuses on antibodies and engineered immune-cell approaches targeting CD123.
Collaborations
Her listed collaborators include Francine Garnache-Ottou and Christophe Ferrand.
Conclusion
Elodie Bole-Richard’s listed invention reflects collaborative research into CD123-targeted antibodies and cellular therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile